Table 1.
Baseline Demographics and Behavioral Characteristicsa
| Among Analysis Population | Among Participants on INSTIs at Entry | ||||||
|---|---|---|---|---|---|---|---|
| Characteristic | Total (N = 4500) | Non-INSTI-Containing Entry Regimen (N = 2652) | INSTI-Containing Entry Regimen (N = 1848) | Entry INSTI = DTG (N = 882) | Entry INSTI = EVG (N = 643) | Entry INSTI = Otherb (N = 323) | |
| DemographicsandBehavioral | |||||||
| Age (years) | Median (Q1, Q3) | 51 (46, 55) | 50 (46, 55) | 51 (47, 56) | 52 (47, 56) | 50 (45, 55) | 51 (47, 55) |
| 40–44 | 801 (18%) | 512 (19%) | 289 (16%) | 114 (13%) | 131 (20%) | 44 (14%) | |
| 45–49 | 1,156 (26%) | 699 (26%) | 457 (25%) | 214 (24%) | 163 (25%) | 80 (25%) | |
| 50–54 | 1,235 (27%) | 706 (27%) | 529 (29%) | 239 (27%) | 183 (28%) | 107 (33%) | |
| 55–59 | 886 (20%) | 497 (19%) | 389 (21%) | 212 (24%) | 110 (17%) | 67 (21%) | |
| 60+ | 422 (9%) | 238 (9%) | 184 (10%) | 103 (12%) | 56 (9%) | 25 (8%) | |
| Natal sex | Female | 1040 (23%) | 675 (25%) | 365 (20%) | 174 (20%) | 117 (18%) | 74 (23%) |
| Male | 3460 (77%) | 1977 (75%) | 1483 (80%) | 708 (80%) | 526 (82%) | 249 (77%) | |
| Gender identity | Cisgender | 4200 (93%) | 2492 (94%) | 1708 (92%) | 821 (93%) | 592 (92%) | 295 (91%) |
| Transgender Spectrum | 91 (2%) | 46 (2%) | 45 (2%) | 21 (2%) | 17 (3%) | 7 (2%) | |
| Not reported | 209 (5%) | 114 (4%) | 95 (5%) | 40 (5%) | 34 (5%) | 21 (7%) | |
| Race | Black or African American | 1799 (40%) | 1073 (40%) | 726 (39%) | 357 (40%) | 254 (40%) | 115 (36%) |
| White | 2210 (49%) | 1204 (45%) | 1006 (54%) | 478 (54%) | 348 (54%) | 180 (56%) | |
| Other | 491 (11%) | 375 (14%) | 116 (6%) | 47 (5%) | 41 (6%) | 28 (9%) | |
| Ethnicity | Hispanic or Latino | 569 (13%) | 286 (11%) | 283 (15%) | 123 (14%) | 106 (16%) | 54 (17%) |
| Not Applicable | 1323 (29%) | 1163 (44%) | 160 (9%) | 103 (12%) | 24 (4%) | 33 (10%) | |
| Not Hispanic or Latino | 2608 (58%) | 1203 (45%) | 1405 (76%) | 656 (74%) | 513 (80%) | 236 (73%) | |
| Country of Enrollment | USA/Canada | 3,177 (71%) | 1489 (56%) | 1688 (91%) | 779 (88%) | 619 (96%) | 290 (90%) |
| Brazil | 912 (20%) | 851 (32%) | 61 (3%) | 45 (5%) | 0 (0%) | 16 (5%) | |
| Spain | 179 (4%) | 84 (3%) | 95 (5%) | 58 (7%) | 24 (4%) | 13 (4%) | |
| Haiti | 123 (3%) | 123 (5%) | 0 (0%) | ||||
| Peru | 109 (2%) | 105 (4%) | 4 (<0.5%) | 0 (0%) | 0 (0%) | 4 (1%) | |
| Smoking status | Current | 1271 (28%) | 729 (28%) | 542 (29%) | 273 (31%) | 184 (29%) | 85 (26%) |
| Former | 1300 (29%) | 722 (27%) | 578 (31%) | 262 (30%) | 207 (32%) | 109 (34%) | |
| Never | 1921 (43%) | 1198 (45%) | 723 (39%) | 344 (39%) | 252 (39%) | 127 (40%) | |
| Substance use | Current | 124 (3%) | 78 (3%) | 46 (2%) | 21 (2%) | 20 (3%) | 5 (2%) |
| Former | 1818 (40%) | 900 (34%) | 918 (50%) | 429 (49%) | 320 (50%) | 169 (53%) | |
| Never | 2551 (57%) | 1671 (63%) | 880 (48%) | 430 (49%) | 303 (47%) | 147 (46%) | |
Abbreviations: DTG, dolutegravir; EVG, elvitegravir; INSTI, integrase-strand transfer inhibitor;
a
All statistics are calculated with data collected from participants.
b
“Other” race includes participants who self-identify as follows: native or indigenous to the enrollment region; more than 1 race (with no single race noted as predominant); or of unknown race.